These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38039716)

  • 21. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice.
    Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA
    J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke.
    Ismael S; Zhao L; Nasoohi S; Ishrat T
    Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
    Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M
    PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.
    Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W
    J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
    Sui A; Chen X; Shen J; Demetriades AM; Yao Y; Yao Y; Zhu Y; Shen X; Xie B
    Cell Death Dis; 2020 Oct; 11(10):901. PubMed ID: 33093455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke.
    Bellut M; Papp L; Bieber M; Kraft P; Stoll G; Schuhmann MK
    Cell Death Dis; 2021 Dec; 13(1):20. PubMed ID: 34930895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nlrp3 Inflammasome Inhibitor MCC950 Ameliorates Obliterative Bronchiolitis by Inhibiting Th1/Th17 Response and Promoting Treg Response After Orthotopic Tracheal Transplantation in Mice.
    Xu KY; Tong S; Wu CY; Ding XC; Chen JL; Ming Y; Wang SH
    Transplantation; 2020 Jun; 104(6):e151-e163. PubMed ID: 32108749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
    Luo Y; Lu J; Ruan W; Guo X; Chen S
    Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome.
    Li H; Guan Y; Liang B; Ding P; Hou X; Wei W; Ma Y
    Eur J Pharmacol; 2022 Aug; 928():175091. PubMed ID: 35714692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.
    Ward R; Li W; Abdul Y; Jackson L; Dong G; Jamil S; Filosa J; Fagan SC; Ergul A
    Pharmacol Res; 2019 Apr; 142():237-250. PubMed ID: 30818045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury.
    Li D; Li C; Wang T; Zhang C; Zhu Z; Zhang G; Fang B
    Int Immunopharmacol; 2021 Nov; 100():108106. PubMed ID: 34530204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
    Zheng G; Xu J; He F; Hu J; Ge W; Ji X; Wang C; Bradley JL; Peberdy MA; Ornato JP; Toldo S; Wang T; Tang W
    Biomed Pharmacother; 2021 Nov; 143():112093. PubMed ID: 34474352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
    Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
    Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo.
    Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y
    Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of MCC950 on nerve injury in rats with intracerebral hemorrhage].
    Guo YJ; Ren J; Liu H; Li TT; Zhang S; Wang H
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jan; 38(1):11-16. PubMed ID: 35634663
    [No Abstract]   [Full Text] [Related]  

  • 37. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole‑kindled mice.
    Wang L; Ding J; Zhu C; Guo B; Yang W; He W; Li X; Wang Y; Li W; Wang F; Sun T
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34676876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice.
    He N; Zheng X; He T; Shen G; Wang K; Hu J; Zheng M; Ding Y; Song X; Zhong J; Chen YY; Wang LL; Yueliang S
    CNS Neurol Disord Drug Targets; 2021 Oct; 20(3):298-308. PubMed ID: 33023460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
    Coll RC; Robertson AA; Chae JJ; Higgins SC; Muñoz-Planillo R; Inserra MC; Vetter I; Dungan LS; Monks BG; Stutz A; Croker DE; Butler MS; Haneklaus M; Sutton CE; Núñez G; Latz E; Kastner DL; Mills KH; Masters SL; Schroder K; Cooper MA; O'Neill LA
    Nat Med; 2015 Mar; 21(3):248-55. PubMed ID: 25686105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.